DocMorris
DOCM.SW
#7769
Rank
NZ$0.58 B
Marketcap
NZ$12.06
Share price
-0.18%
Change (1 day)
-69.25%
Change (1 year)

P/E ratio for DocMorris (DOCM.SW)

P/E ratio at the end of 2024: -5.73

According to DocMorris's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.6181. At the end of 2024 the company had a P/E ratio of -5.73.

P/E ratio history for DocMorris from 2017 to 2024

PE ratio at the end of each year

Year P/E ratio Change
2024-5.73-124.87%
202323.0-691.5%
2022-3.89-83.83%
2021-24.1-44.9%
2020-43.7-2.75%
2019-44.919.42%
2018-37.6-17.44%
2017-45.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Redcare Pharmacy
RDC.DE
-24.7 1,423.77%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.